![Matthew McManus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 543 369 $ al 30/06/2026
Matthew F.
McManus is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/02/2026 | 7.691 ( 0 % ) | 543 369 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Ansa Biotechnologies, Inc.
 Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Presidente | 22/02/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 01/03/2026 |
| AZENTA, INC. | Director de Operaciones | 14/10/2022 |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Director Ejecutivo | - |
The Cleveland Clinic Foundation
 The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 02/01/2010 |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Azenta, Inc.
 Azenta, Inc. Medical/Nursing ServicesHealth Services Provides gene sequencing and gene synthesis services and develops automated ultra-cold storage systems | Health Services |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
